129 related articles for article (PubMed ID: 23231661)
1. The -2T/C polymorphism in the adrenocorticotropin receptor gene affects stress perception of patients with alopecia areata.
Guo HW; Guo H; Li KS; Wu J; Yang SY; Liu BH; Hao F; Bai Y
Int J Dermatol; 2013 Apr; 52(4):441-5. PubMed ID: 23231661
[TBL] [Abstract][Full Text] [Related]
2. Stress in patients with alopecia areata and vitiligo.
Manolache L; Benea V
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):921-8. PubMed ID: 17659001
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor alpha promoter-308G/A polymorphism in Mexican patients with patchy alopecia areata.
Cristina CS; Mauricio SS; Armando LR; Celia SD; Clara RI; Rocío OL; Oliverio W; Jorge OC
Int J Dermatol; 2012 May; 51(5):571-5. PubMed ID: 22515582
[TBL] [Abstract][Full Text] [Related]
4. Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata.
Shimizu T; Hizawa N; Honda A; Zhao Y; Abe R; Watanabe H; Nishihira J; Nishimura M; Shimizu H
Genes Immun; 2005 Jun; 6(4):285-9. PubMed ID: 15815686
[TBL] [Abstract][Full Text] [Related]
5. The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population.
Kalkan G; Karakus N; Baş Y; Takçı Z; Ozuğuz P; Ateş O; Yigit S
Gene; 2013 Sep; 527(2):565-9. PubMed ID: 23831512
[TBL] [Abstract][Full Text] [Related]
6. The protective role of the HLA-DR locus in patients with various clinical types of alopecia areata.
Broniarczyk-Dyła G; Prusińska-Bratoś M; Dubla-Berner M; Arkuszewska C; Borowiec M; Kowalski ML; Woszczek G
Arch Immunol Ther Exp (Warsz); 2002; 50(5):333-6. PubMed ID: 12455867
[TBL] [Abstract][Full Text] [Related]
7. Genetic association of HLA-DQB1 and HLA-DRB1 polymorphisms with alopecia areata in the Italian population.
Megiorni F; Pizzuti A; Mora B; Rizzuti A; Garelli V; Maxia C; Carlesimo M; Fotruna MC; Delle Chiaie R; Cavaggioni G; Rossi A
Br J Dermatol; 2011 Oct; 165(4):823-7. PubMed ID: 21692766
[TBL] [Abstract][Full Text] [Related]
8. A case series of alopecia areata in children: impact of personal and family history of stress and autoimmunity.
Kakourou T; Karachristou K; Chrousos G
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):356-9. PubMed ID: 17309458
[TBL] [Abstract][Full Text] [Related]
9. PTPN22 gene polymorphism in Egyptian alopecia areata patients and its impact on response to diphencyprone immunotherapy.
El-Zawahry BM; Azzam OA; Zaki NS; Abdel-Raheem HM; Bassiouny DA; Khorshied MM
Gene; 2013 Jul; 523(2):147-51. PubMed ID: 23570882
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of autoimmune regulator haplotypes in alopecia areata.
Wengraf DA; McDonagh AJ; Lovewell TR; Vasilopoulos Y; Macdonald-Hull SP; Cork MJ; Messenger AG; Tazi-Ahnini R
Tissue Antigens; 2008 Mar; 71(3):206-12. PubMed ID: 18194361
[TBL] [Abstract][Full Text] [Related]
11. The TRAF1/C5 locus confers risk for familial and severe alopecia areata.
Redler S; Brockschmidt FF; Forstbauer L; Giehl KA; Herold C; Eigelshoven S; Hanneken S; De Weert J; Lutz G; Wolff H; Kruse R; Blaumeiser B; Böhm M; Becker T; Nöthen MM; Betz RC
Br J Dermatol; 2010 Apr; 162(4):866-9. PubMed ID: 20030635
[TBL] [Abstract][Full Text] [Related]
12. Clinical profile and impact on quality of life: seven years experience with patients of alopecia areata.
Al-Mutairi N; Eldin ON
Indian J Dermatol Venereol Leprol; 2011; 77(4):489-93. PubMed ID: 21727697
[TBL] [Abstract][Full Text] [Related]
13. The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areata.
Betz RC; König K; Flaquer A; Redler S; Eigelshoven S; Kortüm AK; Hanneken S; Hillmer A; Tüting T; Lambert J; De Weert J; Kruse R; Lutz G; Blaumeiser B; Nöthen MM
Br J Dermatol; 2008 Feb; 158(2):389-91. PubMed ID: 18028494
[TBL] [Abstract][Full Text] [Related]
14. Psychiatric comorbidities in patients with alopecia areata in Taiwan: a case-control study.
Chu SY; Chen YJ; Tseng WC; Lin MW; Chen TJ; Hwang CY; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
Br J Dermatol; 2012 Mar; 166(3):525-31. PubMed ID: 22049923
[TBL] [Abstract][Full Text] [Related]
15. The non-synonymous C1858T substitution in the PTPN22 gene is associated with susceptibility to the severe forms of alopecia areata.
Kemp EH; McDonagh AJ; Wengraf DA; Messenger AG; Gawkrodger DJ; Cork MJ; Tazi-Ahnini R
Hum Immunol; 2006 Jul; 67(7):535-9. PubMed ID: 16829308
[TBL] [Abstract][Full Text] [Related]
16. Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of alopecia areata.
Kalkan G; Ateş O; Karakuş N; Sezer S
Arch Dermatol Res; 2013 Dec; 305(10):909-15. PubMed ID: 23591741
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in Korean patients with alopecia areata.
Hong SB; Jin SY; Park HJ; Jung JH; Sim WY
J Korean Med Sci; 2006 Feb; 21(1):90-4. PubMed ID: 16479072
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity of corticotropin-releasing hormone, adrenocorticotropic hormone and alpha-melanocyte-stimulating hormone in alopecia areata.
Kim HS; Cho DH; Kim HJ; Lee JY; Cho BK; Park HJ
Exp Dermatol; 2006 Jul; 15(7):515-22. PubMed ID: 16761960
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor gene polymorphisms are not associated with alopecia areata.
Akar A; Orkunoglu FE; Tunca M; Taştan HB; Kurumlu Z
Int J Dermatol; 2007 Sep; 46(9):927-9. PubMed ID: 17822494
[TBL] [Abstract][Full Text] [Related]
20. An implication for post-transcriptional control: reciprocal changes of melanocortin receptor type 2 mRNA and protein expression in alopecia areata.
Guo HW; Deng J; Yang XC; Yang SY; Liu BH; Hao F
Med Hypotheses; 2011 Jan; 76(1):122-4. PubMed ID: 20884125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
